Your therapy is unique and important to patients. At NECSTGEN we enable the next generation of therapies by offering development support and GMP production of cell and gene therapies.
The rapid developments in cell and gene therapy research and the industry as a whole provide remedies to increasingly more patients while offering the potential to decrease the burden on society. NECSTGEN will support clinicians, academic groups and small industrial therapy developers globally to bring cell and gene therapies to patients.
We are happy to announce the official launch of the Netherlands Center for the Clinical Advancement of Stem Cell & Gene Therapies (NECSTGEN). The new center has been established to accelerate the development and clinical realization of cell and...
A collaboration between Regenerative Medicine Crossing Borders (RegMed XB) and the Dutch CardioVascular Alliance (DCVA) will receive an investment of 8 million euros from the Dutch government to set up a new valorisation platform.
League of European Research Universities (LERU):
Improve patient access to Advanced Therapy Medicinal Products